The use of β-blockers after myocardial infarction: no doubts remain

Nat Rev Cardiol. 2026 Jan 19. doi: 10.1038/s41569-026-01252-4. Online ahead of print.

Dan Atar^{1

2}, John Munkhaugen^{3

4}, Eva Irene Bossano Prescott⁵, Tomas Jernberg⁶, Borja Ibáñez⁷

¹ Department of Cardiology, Oslo University Hospital Ulleval, Oslo, Norway. danat@uio.no.
² Institute of Clinical Sciences, University of Oslo, Oslo, Norway. danat@uio.no.
³ Department of Medicine, Drammen Hospital, Vestre Viken Trust, Drammen, Norway.
⁴ Department of Behavioral Medicine, University of Oslo, Oslo, Norway.
⁵ Division of Cardiology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
⁶ Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
⁷ Centro Nacional de Investigaciones Cardiovasculares (CNIC) & Department of Cardiology, Instituto de Investigacion Sanitaria-Fundacion Jimenez Diaz-UAM, Madrid, Spain.

No abstract available

Publication types